Northern Trust Corp Trims Stock Position in Sotera Health Company $SHC

Key Points

• Northern Trust Corp reduced its stake in Sotera Health Company by 2.0%, owning 1,307,166 shares valued at approximately $15.24 million after selling 27,201 shares in the 1st quarter.
• Several institutional investors have increased their stakes in Sotera Health, with Farther Finance Advisors LLC boosting its holdings by 4,881.9%, now owning 6,327 shares worth $70,000.
• Sotera Health reported $0.20 earnings per share for the quarter, exceeding analyst expectations, and noted a revenue increase of 6.4% year-over-year, setting FY 2025 EPS guidance between 0.750-0.820.

Northern Trust Corp trimmed its stake in Sotera Health Company (NASDAQ:SHC - Free Report) by 2.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,307,166 shares of the company's stock after selling 27,201 shares during the period. Northern Trust Corp owned 0.46% of Sotera Health worth $15,242,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of SHC. Farther Finance Advisors LLC lifted its holdings in Sotera Health by 4,881.9% in the first quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company's stock worth $70,000 after buying an additional 6,200 shares during the period. Teacher Retirement System of Texas bought a new position in shares of Sotera Health in the 1st quarter worth approximately $266,000. BNP Paribas Financial Markets purchased a new position in shares of Sotera Health in the 4th quarter valued at approximately $208,000. Principal Financial Group Inc. boosted its position in shares of Sotera Health by 0.3% during the first quarter. Principal Financial Group Inc. now owns 352,388 shares of the company's stock valued at $4,109,000 after purchasing an additional 1,037 shares in the last quarter. Finally, Ananym Capital Management LP bought a new stake in shares of Sotera Health during the fourth quarter valued at approximately $13,680,000. Hedge funds and other institutional investors own 91.03% of the company's stock.

Insider Buying and Selling at Sotera Health

In related news, insider Michael P. Rutz sold 126,611 shares of the company's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $16.38, for a total value of $2,073,888.18. Following the completion of the transaction, the insider owned 450,204 shares of the company's stock, valued at approximately $7,374,341.52. This represents a 21.95% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 55.12% of the company's stock.

Analysts Set New Price Targets

Several brokerages recently commented on SHC. Barclays reissued an "overweight" rating on shares of Sotera Health in a research report on Friday, August 8th. Wall Street Zen upgraded shares of Sotera Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 16th. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, Sotera Health has an average rating of "Moderate Buy" and a consensus target price of $16.00.

Sotera Health Trading Down 1.1%

NASDAQ:SHC opened at $15.98 on Thursday. The firm has a market capitalization of $4.54 billion, a price-to-earnings ratio of 199.77 and a beta of 1.84. The company has a debt-to-equity ratio of 4.49, a current ratio of 2.47 and a quick ratio of 2.23. The business has a fifty day moving average price of $13.17 and a 200-day moving average price of $12.32. Sotera Health Company has a one year low of $9.53 and a one year high of $17.08.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its quarterly earnings data on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.17 by $0.03. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The company had revenue of $294.34 million during the quarter, compared to the consensus estimate of $275.81 million. During the same period in the previous year, the company posted $0.19 EPS. The firm's revenue was up 6.4% on a year-over-year basis. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. Sell-side analysts forecast that Sotera Health Company will post 0.61 EPS for the current year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.